Table 4.
Project DETECT part 3 enrollment and follow-up (September 2015 to March 2019).
| Part 3 follow-up | Project DETECTa part 3 participants n=27 n (%) | ||
| Enrolled | 27 (100) | ||
| Completed follow-up | 23 (85.2) | ||
|
|
False positiveb | 5 (18.5) | |
|
|
Concordant positive results with full seroconversion | 10 (37.0) | |
|
|
Discordant through follow-up | 8 (29.6) | |
|
|
|
Persistent discordance without seroreversion | 1 (3.7) |
|
|
|
Persistent discordance with partial seroreversionb | 7 (25.9) |
| Lost to follow-up | 4 (14.8) | ||
aDETECT: Diagnostic Evaluation To Expand Critical Testing Technologies.
bA false positive is confirmed by a negative viral load result (target not detected) by the RealTime HIV-1 viral load assay (Abbott Laboratories).
cSeroreversion is defined as having at least one point-of-care test result that is positive or reactive followed by a negative or nonreactive test result at a subsequent visit.